Selecta Biosciences Inc. (SELB)
NASDAQ: SELB
· Real-Time Price · USD
0.88
-0.08 (-8.12%)
At close: Nov 13, 2023, 10:00 PM
Selecta Biosciences Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -17.71M | -35.37M | -46.78M | -9M | -11.39M | -21.66M | 5.89M | -7.89M | 8.6M | 28.78M | 12.24M | -17.89M | 4.57M | -24.6M |
Depreciation & Amortization | 1.16M | 580K | 300K | 189K | 176K | 206K | 241K | 350K | 345K | 351K | 401K | 339K | 305K | 207K |
Stock-Based Compensation | 2.51M | -1.8M | -1.39M | 2.32M | 3.78M | 2.28M | 2.28M | 2.6M | 3.56M | 2.75M | 2.25M | 1.9M | 1.78M | 1.78M |
Other Working Capital | n/a | -3.47M | 1.63M | -976K | -654K | 5.1M | -7.47M | -14.41M | -15.32M | -26.89M | -33.92M | 2.42M | -7.81M | -5.98M |
Other Non-Cash Items | n/a | 40M | 44.2M | 358K | 561K | 4.81M | -13.22M | 6.63M | 494K | 676K | -8.48M | -94K | -4.32M | 17.42M |
Deferred Income Tax | n/a | 9.68M | 9.39M | -3.05M | -6.34M | n/a | n/a | 321K | 4.65M | -18.66M | -8.98M | -583K | -4.81M | 16.76M |
Change in Working Capital | n/a | -8.88M | -3.28M | -34K | 3.31M | 5.6M | -7.04M | 2.35M | -29.92M | -25.76M | -37.88M | 5M | -8.37M | -6.94M |
Operating Cash Flow | -23.11M | 4.2M | 2.44M | -9.21M | -9.89M | -8.77M | -11.85M | 4.35M | -12.27M | -11.86M | -31.46M | -10.75M | -6.04M | -12.13M |
Capital Expenditures | -1.07M | -8.95M | -8.38M | n/a | -12K | -130K | -211K | -436K | -99K | -455K | -278K | -164K | -618K | -25K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 29.5M | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -33.5M | n/a | n/a | n/a | -8.04M | -2M | -22.42M |
Sales Maturities Of Investments | n/a | -28.25M | n/a | n/a | n/a | 28.25M | 5.7M | 4M | n/a | 10M | 10M | n/a | n/a | n/a |
Other Investing Acitivies | n/a | 351K | n/a | n/a | n/a | n/a | n/a | -29.5M | n/a | n/a | n/a | 6.4M | n/a | n/a |
Investing Cash Flow | -1.07M | -36.85M | -8.38M | n/a | -12K | 28.12M | 5.49M | -29.94M | -99K | 9.54M | 9.72M | -1.8M | -2.62M | -22.45M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | -149K | n/a | n/a | n/a | 149K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -8.03M | 180.67M | 179.89M | -24.79M | -2.59M | 149K | n/a | 612K | 36.88M | 1.73M | 21.16M | 1.45M | 8.98M | 21.31M |
Financial Cash Flow | -8.03M | 195.65M | 195.02M | -24.79M | -2.59M | 149K | n/a | 612K | 36.88M | 1.73M | 21.16M | 1.45M | 8.98M | 21.31M |
Net Cash Flow | -32.18M | 133.3M | 139.89M | -34.02M | -12.52M | 19.49M | -6.41M | -24.99M | 24.62M | -620K | -588K | -11.1M | 342K | -13.28M |
Free Cash Flow | -24.18M | -4.75M | -5.94M | -9.21M | -9.91M | -8.89M | -12.06M | 3.92M | -12.37M | -12.32M | -31.74M | -10.91M | -6.66M | -12.16M |